Access Clinical Trials Collective Terpenes 
The Cannigma
JULY 1, 2022
Because of this variability in the plant, and because of a lack of standard methods–like chemical analyses of cannabinoids or terpenes–has led to inconsistent scientific results. This is because these types of studies control the most variables to ensure that the results that come out of the trial are as reliable as possible.
The Cannigma
DECEMBER 12, 2022
Turning down activity in the DMN allows better access to new areas of the brain, which can boost creativity and improve problem solving. Clinical research: Research is focusing on 5-MeO-DMT use in depression and anxiety. As such, there have been numerous clinical trials using ketamine.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Joint Blog
FEBRUARY 18, 2020
For the study Israeli investigators examined 59 patients with ADHD who possessed a license from the Ministry of Health to access medical cannabis products. Data on demographics, ADHD, sleep, and anxiety were collected using self-report questionnaires. 9-tetrahydrocannabinol (THC).
The Cannigma
FEBRUARY 11, 2021
Listen & Subscribe: When Mara Gordon started using medical cannabis there wasn’t any lab testing — or any way to know how much of each cannabinoid or terpene was in a given strain. One of the things she does is collect and analyze data about cannabis products and how patients with different medical conditions respond to them.
Cannabis Law Report
NOVEMBER 7, 2019
As of August 2019, authorities in Australia have granted approximately 14,500 approvals, under the Special Access Scheme, for the legal use of medicinal cannabis. With a strong focus on research and development ranging from agronomic research through to clinical trials Cannatrek has an extensive R&D portfolio from Seed to Patient.
The Cannigma
MARCH 12, 2021
At the end of the episode, Debbie Churgai, executive director of Americans for Safe Access, discusses the various ways that military veterans — who could very much benefit from medical cannabis — have difficulty accessing it and the ways that the Veterans Administration can address that issue. Produced by Michael Schaeffer Omer-Man.
Cannabis Law Report
NOVEMBER 24, 2021
However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. Patients can legally access medicinal cannabis through a doctor, via the TGA’s Authorised Prescribers and Special Access schemes.
Expert insights. Personalized for you.
108 
Let's personalize your content